Sudarshan Paramsothy
11PUBLICATIONS
67CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Feb 11, 2025
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference.Loris R Lopetuso, Sara Deleu, Pierluigi Puca
|Jan 09, 2025
Infliximab and Adalimumab in the Treatment of Fistulizing Crohn's Disease: A Propensity Score-Matched Analysis From the Prospective Persistence Australian National IBD Cohort (PANIC4) Study.John David Chetwood, Sudarshan Paramsothy, Rupert W Leong
|Mar 27, 2024
Profiling the colonic mucosal response to fecal microbiota transplantation identifies a role for GBP5 in colitis in humans and mice.Laurence D W Luu, Abhimanu Pandey, Sudarshan Paramsothy
|Jan 26, 2024
Biological Agents in the Treatment of Crohn's Disease: A Propensity Score-Matched Analysis From the Prospective Persistence Australian National IBD Cohort (PANIC3) Study.John David Chetwood, Yanna Ko, Aviv Pudipeddi
|Aug 17, 2023
Key metabolomic alterations are associated with ulcerative colitis disease state and activity: a validation analysis.John David Chetwood, Sudarshan Paramsothy, Craig Haifer
|Apr 18, 2023
Adalimumab originator versus adalimumab biosimilars in inflammatory bowel disease in Australia.Emilia Anderson, Karen Waller, Aravind Gokul Tamilarasan
Pageof 2
Frequent Collaborators
7 joint publications
Rupert W Leong
3 joint publications
Craig Haifer
3 joint publications
John David Chetwood
3 joint publications
Thomas J Borody
3 joint publications
Nadeem O Kaakoush
2 joint publications
Karen Waller
2 joint publications
Yanna Ko
1 joint publications
Lito E Papanicolas
1 joint publications
Samuel P Costello
1 joint publications
Jakob Begun
